Table 2.
Percentage of students reaching correct and incorrect exits for each DBT
| DBT No | DBT Related Topic | Correct (%) | Incorrect (%) | DBT No | DBT Related Topic | Correct (%) | Incorrect (%) |
|---|---|---|---|---|---|---|---|
| DBT1 | Phase studies | 24(21.4) | 88(78.6) | DBT9 | Affinity and intrinsic activity | 26(23.2) | 86(76.8) |
| DBT2 | Sources and nomenclature of drugs | 82(73.2) | 30(26.8) | DBT10 | Ligands and spare receptors | 47(42) | 65(58) |
| DBT3 | Absorption | 76(67.9) | 36(32.1) | DBT11 | G-protein coupled receptors | 34(30.4) | 78(69.6) |
| DBT4 | Distribution | 55(49.1) | 57(50.9) | DBT12 | Receptor types | 34(30.4) | 78(69.6) |
| DBT5 | Metabolism | 30(26.8) | 82(73.2) | DBT13 | Penicillins-1 | 72(64.3) | 40(35.7) |
| DBT6 | Elimination | 48(42.9) | 64(57.1) | DBT14 | Penicillins-2 | 45(40.2) | 67(59.8) |
| DBT7 | Types of antagonism | 41(36.6) | 71(63.4) | DBT15 | Penicillins-3 | 32(28.6) | 80(71.4) |
| DBT8 | Dose-response relationship | 5(4.5) | 107(95.5) | DBT16 | Cephalosporins | 37(33) | 75(67) |